Literature DB >> 16177086

Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200.

Ikuo Shiratori1, Masao Yamaguchi, Maho Suzukawa, Kazuhiko Yamamoto, Lewis L Lanier, Takashi Saito, Hisashi Arase.   

Abstract

Human and rodent CD200 are recognized by the inhibitory CD200R, and these molecules play an important role in the regulation of the immune system. Several viruses, such as human herpesvirus-6 (HHV-6), HHV-7, and HHV-8, possess a CD200 homologue, suggesting that these viruses regulate the immune response via CD200R. In this study, we analyzed the effect of human CD200 and the viral CD200 homologues on human CD200R-expressing cells. We found that human CD200R is predominantly expressed on basophils in amounts higher than on other human peripheral blood leukocytes. Furthermore, the viral CD200 homologues as well as human CD200 were recognized by human CD200R, and the activation of basophils was down-regulated by these CD200 proteins. These results suggested that CD200R is an important regulatory molecule of basophil activation. In addition, the presence of CD200 homologues on several viruses suggests a potentially unique relationship between basophil function and viral infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177086     DOI: 10.4049/jimmunol.175.7.4441

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

2.  Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.

Authors:  Robin Mihrshahi; Marion H Brown
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

3.  Herpesvirus orthologues of CD200 bind host CD200R but not related activating receptors.

Authors:  Lai Shan Kwong; Munir Akkaya; A Neil Barclay; Deborah Hatherley
Journal:  J Gen Virol       Date:  2015-11-04       Impact factor: 3.891

4.  Endothelial CD200 is heterogeneously distributed, regulated and involved in immune cell-endothelium interactions.

Authors:  Ya-Chen Ko; Hsiung-Fei Chien; Ya-Fen Jiang-Shieh; Chiu-Yun Chang; Man-Hui Pai; Jian-Pei Huang; Hui-Min Chen; Ching-Hsiang Wu
Journal:  J Anat       Date:  2009-01       Impact factor: 2.610

5.  Cytomegalovirus e127 protein interacts with the inhibitory CD200 receptor.

Authors:  Mildred Foster-Cuevas; Tina Westerholt; Mohamed Ahmed; Marion H Brown; A Neil Barclay; Sebastian Voigt
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

6.  Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein.

Authors:  Mohamed A El-Mokhtar; Agnieszka Bauer; Julia Madela; Sebastian Voigt
Journal:  Med Microbiol Immunol       Date:  2018-07-21       Impact factor: 3.402

7.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  The rhesus rhadinovirus CD200 homologue affects immune responses and viral loads during in vivo infection.

Authors:  Ryan D Estep; Stephanie D Rawlings; Helen Li; Minsha Manoharan; Elizabeth T Blaine; Megan A O'Connor; Ilhem Messaoudi; Michael K Axthelm; Scott W Wong
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

9.  PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B.

Authors:  Takeshi Satoh; Jun Arii; Tadahiro Suenaga; Jing Wang; Amane Kogure; Junji Uehori; Noriko Arase; Ikuo Shiratori; Shinya Tanaka; Yasushi Kawaguchi; Patricia G Spear; Lewis L Lanier; Hisashi Arase
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

10.  Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.

Authors:  Robin Mihrshahi; A Neil Barclay; Marion H Brown
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.